In vitro release of metoclopramide from hydrophobic matrix tablets. influence of hydrodynamic conditions on kinetic release parameters.
There has been growing interest in the subject of drug delivery and the design and evaluation of controlled-release systems. The simplest way to control the release of an active agent is to disperse it in an inert polymeric matrix. Controlled-release systems are of interest because they are technologically simple, relatively cheap, and practically unaffected by physiological changes. In this study, a new matrix system was formed by an active principle, metoclopramide hydrochloride, scattered into a biocompatible hydrophobic polymerical mesh, polyamide 12, to achieve sustained and controlled delivery of metoclopramide hydrochloride. This research was conducted to investigate the in vitro drug release behavior from these new inert polymeric matrix tablets. The drug release process was investigated both experimentally and by means of mathematical models. Different models were applied for the evaluation of drug release data. On the basis of our results, a biexponential equation was proposed, Q=Qfast(1)(1 - e(-Kfast t)) + Qslow(2)(1 - e(-Kslow t)), in an attempt to explain the mechanism responsible for the release process. Additionally, the influence of the experimental conditions of the dissolution devices, such as rate of flow and pH of dissolution medium, on the parameters that characterize the release mechanism was studied, and it was found that the main factor was the hydrodynamic condition of rate of flow.
Frutos
P
P
Department of Pharmaceutical Technology, Complutense University, Madrid, Spain. pafrutos@eucmax.sim.ucm.es
Pabón
C
C
Lastres
J L
JL
Frutos
G
G
D000465:Algorithms; D000932:Antiemetics / Q000008:administration & dosage / Q000737:chemistry*; D019540:Area Under Curve; D003692:Delayed-Action Preparations; D005079:Excipients; D006863:Hydrogen-Ion Concentration; D008787:Metoclopramide / Q000008:administration & dosage / Q000737:chemistry*; D008954:Models, Biological; D012995:Solubility; D013607:Tablets
D000932:Antiemetics; D003692:Delayed-Action Preparations; D005079:Excipients; D013607:Tablets; D008787:Metoclopramide